These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38189365)

  • 1. Low-Dose Colchicine for the Prevention of Cardiovascular Events After Acute Coronary Syndrome.
    Gera P; Wasserstein DH; Frishman WH; Aronow WS
    Cardiol Rev; 2024 Jan; ():. PubMed ID: 38189365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.
    Boczar KE; Shin S; deKemp RA; Dowlatshahi D; Tavoosi A; Wiefels C; Liu P; Lochnan H; MacPherson PA; Chong AY; Torres C; Leung E; Tawakol A; Ahmadi A; Garrard L; Lefebvre C; Kelly C; MacPhee P; Tilokee E; Raggi P; Wells GA; Beanlands R
    BMJ Open; 2023 Nov; 13(11):e074463. PubMed ID: 37949621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine's Role in Cardiovascular Disease Management.
    Buckley LF; Libby P
    Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1031-1041. PubMed ID: 38511324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Colchicine a New Game-Changer in Patients With Acute Coronary Syndrome?
    Nawabi AQ; Hassan W; Chen L; Shaikh N; Abbas K; Zehra FT
    Cureus; 2022 Mar; 14(3):e22874. PubMed ID: 35399435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Colchicine in Reducing Inflammatory Biomarkers and Cardiovascular Risk in Coronary Artery Disease: A Meta-analysis of Clinical Trials.
    Sethuramalingam S; Maiti R; Hota D; Srinivasan A
    Am J Ther; 2023 May; 30(3):e197-e208. PubMed ID: 34264887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
    Nidorf SM; Fiolet ATL; Eikelboom JW; Schut A; Opstal TSJ; Bax WA; Budgeon CA; Tijssen JGP; Mosterd A; Cornel JH; Thompson PL;
    Am Heart J; 2019 Dec; 218():46-56. PubMed ID: 31706144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.
    Opstal TSJ; Fiolet ATL; van Broekhoven A; Mosterd A; Eikelboom JW; Nidorf SM; Thompson PL; Duyvendak M; van Eck JWM; van Beek EA; den Hartog F; Budgeon CA; Bax WA; Tijssen JGP; El Messaoudi S; Cornel JH;
    J Am Coll Cardiol; 2021 Aug; 78(9):859-866. PubMed ID: 34446156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine and plaque: A focus on atherosclerosis imaging.
    Aldana-Bitar J; Golub IS; Moore J; Krishnan S; Verghese D; Manubolu VS; Benzing T; Ichikawa K; Hamal S; Kianoush S; Anderson LR; Ramirez NR; Leipsic JA; Karlsberg RP; Budoff MJ
    Prog Cardiovasc Dis; 2024; 84():68-75. PubMed ID: 38423236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review.
    Yong J; Tian J; Jiang W; Zhao X; Zhang H; Song X
    Clin Ther; 2022 Aug; 44(8):1150-1159. PubMed ID: 35907660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine in atherosclerotic cardiovascular disease.
    Tucker B; Goonetilleke N; Patel S; Keech A
    Heart; 2024 Apr; 110(9):618-625. PubMed ID: 38331560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Colchicine in Acute Coronary Syndromes.
    Vaidya K; Martínez G; Patel S
    Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.
    Vaidya K; Arnott C; Martínez GJ; Ng B; McCormack S; Sullivan DR; Celermajer DS; Patel S
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):305-316. PubMed ID: 29055633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: A secondary analysis of a randomized controlled trial.
    Demidowich AP; Wolska A; Wilson SR; Levine JA; Sorokin AV; Brady SM; Remaley AT; Yanovski JA
    J Clin Lipidol; 2019; 13(6):1016-1022.e2. PubMed ID: 31740368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seeing Colchicine in a New Light: Repurposing Low-dose Colchicine for Secondary Prevention of Cardiovascular Disease.
    Nidorf SM
    Clin Ther; 2023 Nov; 45(11):1029-1033. PubMed ID: 37516564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine in Cardiovascular Disease: In-Depth Review.
    Deftereos SG; Beerkens FJ; Shah B; Giannopoulos G; Vrachatis DA; Giotaki SG; Siasos G; Nicolas J; Arnott C; Patel S; Parsons M; Tardif JC; Kovacic JC; Dangas GD
    Circulation; 2022 Jan; 145(1):61-78. PubMed ID: 34965168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing colchicine's journey in view of drug-to-drug interactions. A review.
    Vrachatis DA; Papathanasiou KA; Giotaki SG; Iliodromitis KE; Papaioannou TG; Stefanini GG; Cleman M; Siasos G; Reimers B; Lansky A; Tardif JC; Deftereos SG; Giannopoulos G
    Toxicol Rep; 2021; 8():1389-1393. PubMed ID: 34285885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of Colchicine in preventing coronary vascular disease in childhood-onset lupus: a new view on an old drug.
    Abel D; Ardoin SP; Gorelik M
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):15. PubMed ID: 33593369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.